Maktaba

Item request has been placed!

Item request cannot be made.

Processing Request

Research Starter

Liver.

DEFINITION: A vital organ that contributes to control of blood sugar levels; metabolizes carbohydrates, lipids, and proteins; stores blood, iron, ... More
Salem Press Encyclopedia of Health, 2025. 3p.

Academic Journal

Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers.

Authors : Torre P; Department of Medicine, Surgery and Dentistry, 'Scuola Medica Salernitana', University of Salerno, Via S. Allende, 84081 Baronissi, Italy.; Motta BM

Subjects: Fatty Liver*/Fatty Liver*/Fatty Liver*/genetics ; Fatty Liver*/Fatty Liver*/Fatty Liver*/metabolism ; Fatty Liver*/Fatty Liver*/Fatty Liver*/pathology

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Aug 29; Vol. 26 (17). Date of Electronic Publication: 2025 Aug 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list

Academic Journal

Clinical Variables That Predict Liver-related Events in Steatotic Liver Disease Diagnosed by a Liver Biopsy.

Authors : Okubo S; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, Japan.; Takaki A

Subjects: Liver*/Liver*/Liver*/pathology ; Fatty Liver*/Fatty Liver*/Fatty Liver*/diagnosis ; Fatty Liver*/Fatty Liver*/Fatty Liver*/pathology

Source: Internal medicine (Tokyo, Japan) [Intern Med] 2025 Aug 15; Vol. 64 (16), pp. 2425-2432. Date of Electronic Publication: 2025 Feb 08.Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium:

Record details

Alnustone Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Facilitating Mitochondrial Fatty Acid β-Oxidation via Targeting Calmodulin.

Authors : Hu S; State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong, 250012, China.; National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, Shandong, 250012, China.

Subjects: Calmodulin*/Calmodulin*/Calmodulin*/metabolism ; Calmodulin*/Calmodulin*/Calmodulin*/drug effects ; Fatty Acids*/Fatty Acids*/Fatty Acids*/metabolism

Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2025 Aug; Vol. 12 (31), pp. e11984. Date of Electronic Publication: 2025 Jun 05.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

Read Online Read More Add to Saved list

Academic Journal

Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis.

Authors : Nishimura N; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.; Kaji K

Subjects: Rifaximin*/Rifaximin*/Rifaximin*/pharmacology ; Rifaximin*/Rifaximin*/Rifaximin*/therapeutic use ; Epiregulin*/Epiregulin*/Epiregulin*/metabolism

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jul 12; Vol. 26 (14). Date of Electronic Publication: 2025 Jul 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list

Academic Journal

The unwell patient with advanced chronic liver disease: when to use each score?

Authors : Moore O; Blacktown Clinical School, School of Medicine, Western Sydney University, Blacktown, NSW, Australia.; Blacktown Hospital, Western Sydney Local Health District, Blacktown, NSW, Australia.

Subjects: Severity of Illness Index* ; Liver Diseases*/Liver Diseases*/Liver Diseases*/diagnosis ; Liver Diseases*/Liver Diseases*/Liver Diseases*/mortality

Source: BMC medicine [BMC Med] 2025 Jul 09; Vol. 23 (1), pp. 413. Date of Electronic Publication: 2025 Jul 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

Record details

Read Online Read More Add to Saved list

Academic Journal

Loss of endothelial ZEB2 in mice attenuates steatosis early during metabolic dysfunction-associated steatotic liver disease.

Authors : Dheedene W; Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, Endothelial Cell Biology Unit, KU Leuven, Campus Gasthuisberg, Onderwijs & Navorsing 1, Herestraat 49, box 911, Leuven, 3000, Belgium.; Verhulst S

Subjects: Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/genetics ; Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/metabolism ; Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/deficiency

Source: Scientific reports [Sci Rep] 2025 Jul 02; Vol. 15 (1), pp. 23434. Date of Electronic Publication: 2025 Jul 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Screening for metabolic-associated fatty liver disease in type 2 diabetes patients using non-invasive scores and ultrasound: a cross-sectional study in Egypt.

Authors : Semeya AA; Gastroenterology and Infectious Diseases Department, Benha Teaching Hospital, Benha, El-Qalyubia, Egypt.; Hafez RSAA

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/diagnostic imaging ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/epidemiology

Source: BMC gastroenterology [BMC Gastroenterol] 2025 Sep 15; Vol. 25 (1), pp. 639. Date of Electronic Publication: 2025 Sep 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

Record details

Read Online Read More Add to Saved list

Academic Journal

MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression.

Authors : Asero C; Division of Medicine and Hepatology, University Hospital of Messina, 98124 Messina, Italy.; Department of Clinical and Experimental Medicine, University of Messina, 98124 Messina, Italy.

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Gastrointestinal Microbiome*

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Sep 04; Vol. 26 (17). Date of Electronic Publication: 2025 Sep 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list

Academic Journal

MOFI-FL, a novel score for detecting hepatic steatosis and predicting cardiometabolic mortality.

Authors : Reyes-Barrera J; Doctorado en Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, Ciudad de México, México.; Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano Nº 1, Colonia Sección XVI, México City, C. P. 14030, México.

Subjects: Fatty Liver*/Fatty Liver*/Fatty Liver*/diagnosis ; Fatty Liver*/Fatty Liver*/Fatty Liver*/mortality ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/mortality

Source: Scientific reports [Sci Rep] 2025 Aug 19; Vol. 15 (1), pp. 30363. Date of Electronic Publication: 2025 Aug 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Dynamic changes in liver stiffness measurement by 2D shear-wave elastography predict hepatocellular carcinoma in patients with chronic hepatitis B and well-controlled viremia: a retrospective study.

Authors : Wang N; Department of Medical Ultrasonics, Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong, China.; Wu Y

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnostic imaging ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/etiology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/virology

Source: BMC gastroenterology [BMC Gastroenterol] 2025 Aug 11; Vol. 25 (1), pp. 578. Date of Electronic Publication: 2025 Aug 11.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

Liver.

Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers.

Clinical Variables That Predict Liver-related Events in Steatotic Liver Disease Diagnosed by a Liver Biopsy.

Alnustone Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Facilitating Mitochondrial Fatty Acid β-Oxidation via Targeting Calmodulin.

Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis.

The unwell patient with advanced chronic liver disease: when to use each score?

Loss of endothelial ZEB2 in mice attenuates steatosis early during metabolic dysfunction-associated steatotic liver disease.

Screening for metabolic-associated fatty liver disease in type 2 diabetes patients using non-invasive scores and ultrasound: a cross-sectional study in Egypt.

MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression.

MOFI-FL, a novel score for detecting hepatic steatosis and predicting cardiometabolic mortality.

Dynamic changes in liver stiffness measurement by 2D shear-wave elastography predict hepatocellular carcinoma in patients with chronic hepatitis B and well-controlled viremia: a retrospective study.

Contact

Follow us